Clinical reference Biomarker Directory
Back to directory

Chymotrypsin

Established

Chymotrypsin is a stool-based pancreatic function marker, now largely superseded by fecal elastase-1.

Also known as Fecal chymotrypsin
In plain language

Chymotrypsin is a digestive enzyme once measured in stool to check pancreas function, but a newer, more reliable test (fecal elastase) has mostly replaced it.

Biomarker & context

Chymotrypsin is a digestive enzyme produced by the exocrine pancreas, historically measured in stool as an indirect marker of pancreatic exocrine function.

What it indicates

Low fecal chymotrypsin suggests pancreatic exocrine insufficiency, in which the pancreas fails to produce enough digestive enzymes, leading to malabsorption of fats and nutrients.

Diagnosis & clinical testing

Traditionally measured via stool sample, but fecal chymotrypsin has largely been superseded in modern practice by fecal elastase-1 testing, which is more stable during intestinal transit and less affected by oral pancreatic enzyme supplementation.

Guiding treatment

Confirmed pancreatic exocrine insufficiency is treated with pancreatic enzyme replacement therapy; fecal elastase-1, not chymotrypsin, is now the preferred monitoring test in most clinical settings.

Clinical significance

An older test whose modern equivalent (fecal elastase-1) is now generally preferred in practice.

References
  1. Clinical Chemistry reference texts on pancreatic exocrine function testing; general gastroenterology practice guidance on fecal elastase versus chymotrypsin testing.